Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001933414-26-000086 |
|---|---|
| Form Type | 4 |
| Filing Date | May 19, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
1,251
Total Value
$17,926.83
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | May 18, 2026 | Exercise/Conversion | 417 | $15.44 | $6,438.48 | 63,860 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 18, 2026 | Sale | 417 | $27.55 | $11,488.35 | 63,443 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | May 18, 2026 | Exercise/Conversion | 417 | $0.00 | $0.00 | 4,167 | Direct | โ | View Details |